Article
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.
Neurology - 6 May 2008
Sluimer J D, Vrenken H, Blankenstein M A, Fox N C, Scheltens P, Barkhof F, van der Flier W M
Abstract excerpt
OBJECTIVE: To assess which baseline clinical and MRI measures influence whole-brain atrophy rates, measured from serial MR imaging. METHODS: We recruited 65 patients with Alzheimer disease (mean +/- SD age 70 +/- 8 y, 58% women, Mini-Mental State Examination [MMSE] 22 +/- 5), scanned with an average interval of 1.7 +/- 0.6 years. Whole-brain atrophy rates were used as outcome measure. Baseline normalized brain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
